THE DUBERSTEIN GROUP INC. for PFIZER INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Agriculture appropriations re drug reimportation - HR 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015; S 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Trade (domestic/foreign) TRD
Trans Pacific Partnership negotiations - Executive Branch action re this issue. Trans-Atlantic Trade & Investment Partnership - Executive Branch action re this issue. Trade Promotion Authority - Proposed legislation re this issue; Executive Branch action re this issue. Korea intellectual property issues - Executive Branch action re this issue.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
Taxation/Internal Revenue Code TAX
Comprehensive tax reform, including international taxes, tax extenders, and research and development tax credit, deferral, excess returns/base erosion, territorial systems, patent/innovation box, minimum tax, taxation of intangible income, and base erosion and profit sharing (BEPS) - HR 4453, S Corporation Permanent Tax Relief Act of 2014; HR 4457, America's Small Business Tax Relief Act of 2014; HR 4438, American Research and Competitiveness Act of 2014;S 2260, EXPIRE Act of 2014; proposed legislation re these issues. Proposed merger with AstraZeneca - Hr 4679, Stop Corporate Inversions Act of 2014; S 2360, Stop Corporate Inversions Act of 2014; Congressional oversight.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
Copyright/Patent/Trademark CPT
Patent reform and patent troll legislation - S 1013, Patent Abuse Reduction Act of 2013; S 1612, Patent Litigation Integrity Act of 2013; S 1720, Patent Transparency and Improvements Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
Health Issues HCR
Prescription Drug User Fee Act (PUDFA) implementation - Executive Branch action re this issue.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
Medicare/Medicaid MMM
Medicare rebates; Medicare Part D. Patient Protection and Affordable Care Act implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.